BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10506709)

  • 41. Pathobiology of CD30+ cutaneous T-cell lymphomas.
    Kadin ME
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of lymphomatoid papulosis occurred simultaneously with Ki-1-positive anaplastic large cell lymphoma.
    Lee NS; Cha SW; Hong SJ; Shin WY; Lee GT; Jeon JW; Won JH; Baick SH; Hong DS; Park HS
    Korean J Intern Med; 1997 Jan; 12(1):84-8. PubMed ID: 9159045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphomatoid papulosis: is a second lymphoma commoner among East Asians?
    Gan EY; Tang MB; Tan SH
    Clin Exp Dermatol; 2012 Mar; 37(2):118-21. PubMed ID: 21790721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
    Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lymphomatoid papulosis evolving into malignant lymphoma. Clinico-pathological and immunohistochemical study of 3 cases].
    Bustos de Abajo M; Serrano Ortega S; Medina Cano MT; Aguilar Peña D; Gutiérrez Salmerón MT; Gómez Morales M; García del Moral R
    Med Clin (Barc); 1993 Feb; 100(6):220-2. PubMed ID: 8429728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-4 production by CD8+ lymphomatoid papulosis, type C, attracts background eosinophils.
    Slone SP; Martin AW; Wellhausen SR; Woods DR; Malone JC; Lear SC; Laber DA
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():38-45. PubMed ID: 18537857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Case of regional lymphomatoid papulosis confined to the periorbital areas.
    Kim YJ; Rho YK; Yoo KH; Kim JY; Seo SJ; Hong CK; Moon NJ; Song KY
    J Dermatol; 2009 Mar; 36(3):163-5. PubMed ID: 19335692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Lymphomatoid papulosis].
    Dreno B
    Presse Med; 1995 Jun; 24(23):1084-7. PubMed ID: 7567810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetic findings in regressing skin lesions of lymphomatoid papulosis.
    Peters K; Knoll JH; Kadin ME
    Cancer Genet Cytogenet; 1995 Mar; 80(1):13-6. PubMed ID: 7697626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphomatoid papulosis in a patient with Waldenström's macroglobulinemia.
    Ribeiro-Silva A; Chang D; Arruda D; Félix PR
    J Dermatol; 2005 Feb; 32(2):132-6. PubMed ID: 15906545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphomatoid papulosis followed by Hodgkin's lymphoma. Differential response to therapy.
    Zackheim HS; LeBoit PE; Gordon BI; Glassberg AB
    Arch Dermatol; 1993 Jan; 129(1):86-91. PubMed ID: 8420496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Lymphomatoid papulosis and anaplastic giant-cell lymphoma].
    Moreau-Cabarrot A; Bonafé JL; Gorguet B; Andrieu H; Massip P
    Ann Dermatol Venereol; 1994; 121(10):727-30. PubMed ID: 7793765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma.
    Yagi H; Tokura Y; Furukawa F; Takigawa M
    J Invest Dermatol; 1996 Dec; 107(6):827-32. PubMed ID: 8941669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
    Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
    Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphomatoid papulosis in an HIV-positive man.
    Weinstein A; Mirzabeigi M; Withee M; Vincek V
    AIDS Patient Care STDS; 2004 Oct; 18(10):563-7. PubMed ID: 15630784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis.
    Chott A; Vonderheid EC; Olbricht S; Miao NN; Balk SP; Kadin ME
    J Invest Dermatol; 1996 Apr; 106(4):696-700. PubMed ID: 8618007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphomatoid papulosis localized to the face.
    Dalle S; Balme B; Thomas L
    Dermatol Online J; 2006 Mar; 12(3):9. PubMed ID: 16638423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
    Harvell J; Vaseghi M; Natkunam Y; Kohler S; Kim Y
    J Cutan Pathol; 2002 Feb; 29(2):88-92. PubMed ID: 12150138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
    Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
    Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.